– Proteomics International Laboratories (ASXIQ) was flat at 50c after the medtech company announced the publication of two studies validating its predictive test for diabetic kidney disease. The results form a basis for regulatory approvals related to its PromarkerD test and its adoption by pathology laboratories worldwide, Proteomics said.
Ann: PromarkerD clinical assay performance results published, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.015(4.41%) |
Mkt cap ! $53.14M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $75.67K | 227.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9093 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 2200 | 1 |
View Market Depth
| Last trade - 15.02pm 24/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |